Find Research Projects

Search results

• Active

  Fee Revenue: CON28292 - Immunogenicity and Efficacy Testing of Medical Countermeasures (Vaccines and Other Biologics) Against BSL-4 Pathogens in NHPs

  Urban, R.

  5/19/20 → 8/31/22

  Project: Other project

• Fee Revenue: CON28292 - Immunogenicity and Efficacy Testing of Medical Countermeasures (Vaccines and Other Biologics) Against BSL-4 Pathogens in NHPs

  Urban, R.

  5/19/20 → 8/31/22

  Project: Other project

• Fee Revenue: CON28292 - Immunogenicity and Efficacy Testing of Medical Countermeasures (Vaccines and Other Biologics) Against BSL-4 Pathogens in NHPs

  Urban, R.

  5/19/20 → 8/31/22

  Project: Other project

• COVID-19 Lab Testing Equipment and Supplies

  Ksiazek, T.

  Sealy & Smith Foundation

  5/18/20 → 5/17/22

  Project: Other project

• COVID-19 Lab Testing Equipment and Supplies

  Ksiazek, T.

  Sealy & Smith Foundation

  5/18/20 → 5/17/22

  Project: Other project

• COVID-19 Lab Testing Equipment and Supplies

  Ksiazek, T.

  Sealy & Smith Foundation

  5/18/20 → 5/17/22

  Project: Other project

• COVID-19 Lab Testing Equipment and Supplies

  Ksiazek, T.

  Sealy & Smith Foundation

  5/18/20 → 5/17/22

  Project: Other project

• COVID-19 Lab Testing Equipment and Supplies

  Ksiazek, T.

  Sealy & Smith Foundation

  5/18/20 → 5/17/22

  Project: Other project

• Protocol I6T-MC-AMBG (a) A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis - LUCENT 2

  Cohn, S.

  Eli Lilly & Company

  5/13/20 → 5/12/25

  Project: Other project

• (COMRED) Dilapan vs Misoprostol for Cervical Ripening [COMRED - Comparison of Misoprostol Ripening Efficacy With Dilapan]

  Saad, A.

  Columbia Univ. in the City of New York

  5/11/20 → 5/10/22

  Project: Other project

• Fee Revenue: CON29060 COVID-19 Animal Models

  Urban, R.

  5/8/20 → 8/31/21

  Project: Other project

• Fee Revenue: CON29060 COVID-19 Animal Models

  Urban, R.

  5/8/20 → 8/31/21

  Project: Other project

• Fee Revenue: CON29060 COVID-19 Animal Models

  Urban, R.

  5/8/20 → 8/31/21

  Project: Other project

• C-type Lectin Receptor Pathways in Pathogenesis of TB/HIV Co-Infection

  Endsley, J.

  National Inst of Allergy & Infectious Di

  5/5/20 → 4/30/23

  Project: Other project

• Development of reverse genetic systems and mouse model for SARS-CoV-2

  Rajsbaum Gorodezky, R.

  National Inst of Allergy & Infectious Di

  5/1/20 → 4/30/22

  Project: Other project

• COVID-19 Vaccine Development

  Makino, S.

  Emergent Ventures

  5/1/20 → 4/30/22

  Project: Other project

• GPR120 regulation of inflammatory bowel disease

  Cong, Y.

  National Inst of Diabetes & Digestive &

  5/1/20 → 3/31/23

  Project: Other project

• Inhibitory activities of compounds against coronaviruses

  Shi, P.

  Gilead Sciences, Inc.

  5/1/20 → 4/30/22

  Project: Other project

• Targeting neuroendocrine prostate cancer by engineering 3' untranslated regions

  Wagner, E.

  DUKE UNIVERSITY

  5/1/20 → 4/30/23

  Project: Other project

• Moderna Vaccine Research

  Bukreyev, A.

  ModernaTX Inc

  4/28/20 → 12/1/21

  Project: Other project

• PLASMA ADSORPTION IN PATIENTS WITH CONFIRMED COVID-19 INFECTION

  Yates, S.

  Marker Therapeutics AG

  4/24/20 → 4/23/22

  Project: Other project

• Pathogenic Role of Mechanical Stress in Fibrosis and Tissue Remodeling in Crohn's Disease

  Shi, X.

  National Inst of Diabetes & Digestive &

  4/21/20 → 1/31/24

  Project: Other project

• Fee Revenue: CON29090 - Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Urban, R.

  4/16/20 → 8/31/21

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  Eli Lilly & Company

  4/16/20 → 9/1/21

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  Eli Lilly & Company

  4/16/20 → 9/1/21

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  Eli Lilly & Company

  4/16/20 → 9/1/21

  Project: Other project

• Fee Revenue: CON29090 - Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Urban, R.

  4/16/20 → 8/31/21

  Project: Other project

• Fee Revenue: CON29090 - Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Urban, R.

  4/16/20 → 8/31/21

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  Eli Lilly & Company

  4/16/20 → 9/1/21

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  Eli Lilly & Company

  4/16/20 → 9/1/21

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  Eli Lilly & Company

  4/16/20 → 9/1/21

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Continuation of the nuMoM2b Heart Health Study

  Saade, G.

  RTI International

  4/15/20 → 1/31/27

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• UTMB Clinical and Translational Science Award-Mentored Career Development

  Ameredes, B.

  National Center for Advancing Translatio

  4/8/20 → 3/31/25

  Project: Other project

• UTMB Clinical and Translational Science Award

  Urban, R.

  National Center for Advancing Translatio

  4/8/20 → 3/31/25

  Project: Other project

• UTMB Clinical and Translational Science Award

  Hellmich, M.

  National Center for Advancing Translatio

  4/8/20 → 3/31/25

  Project: Other project

• UTMB Clinical and Translational Science Award

  Urban, R.

  National Center for Advancing Translatio

  4/8/20 → 3/31/25

  Project: Other project

• UTMB Clinical and Translational Science Award

  Hellmich, M.

  National Center for Advancing Translatio

  4/8/20 → 3/31/25

  Project: Other project

• UTMB Clinical and Translational Science Award

  Urban, R.

  National Center for Advancing Translatio

  4/8/20 → 3/31/25

  Project: Other project

• UTMB Clinical and Translational Science Award

  Hellmich, M.

  National Center for Advancing Translatio

  4/8/20 → 3/31/25

  Project: Other project

• UTMB Clinical and Translational Science Award

  Urban, R.

  National Center for Advancing Translatio

  4/8/20 → 3/31/25

  Project: Other project

• UTMB Clinical and Translational Science Award

  Urban, R.

  National Center for Advancing Translatio

  4/8/20 → 3/31/25

  Project: Other project

• UTMB Clinical and Translational Science Award

  Urban, R.

  National Center for Advancing Translatio

  4/8/20 → 3/31/25

  Project: Other project

• UTMB Clinical and Translational Science Award

  Hellmich, M.

  National Center for Advancing Translatio

  4/8/20 → 3/31/25

  Project: Other project

• UTMB Clinical and Translational Science Award

  Hellmich, M.

  National Center for Advancing Translatio

  4/8/20 → 3/31/25

  Project: Other project